Rollover

A rollover, in the context of employer-sponsored 401k plans, refers to the process of transferring funds from one retirement account to another, typically when an employee changes jobs or transitions to a new employer. This transaction enables participants to maintain the tax-deferred status of their retirement savings while consolidating their assets into a single, manageable account.

 

When an individual leaves their current job, they may have the option to rollover their 401k balance into a new retirement account, such as an Individual Retirement Account (IRA), or into the 401k plan offered by their new employer. This strategic move offers several benefits, including the preservation of tax advantages and potential for continued investment growth.

 

  • Example 1: John, a diligent employee, decides to leave his current job for a better opportunity. He chooses to rollover his existing 401k balance into an IRA to maintain control over his investment choices and consolidate his retirement savings.

  • Example 2: Sarah receives a job offer from a different company. She decides to rollover her 401k from her former employer into the new company's 401k plan to keep her retirement accounts organized and simplify her financial management.

  • Example 3: Mark, after years of working for various employers, has multiple 401k accounts scattered across different providers. He decides to perform a rollover of all his previous 401k balances into a single self-directed IRA for better control over his investments and to avoid paying unnecessary fees.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.